We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
News

Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors

Rectangle Image
News

Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors

Read time:
 

He is also a Member of the Advisory Board of Nordic Biotech and BankInvest BioMedical Venture. Dr. Braestrup is a Member of The Royal Danish Scientific Society and The Academy of Technical Sciences. He holds M.Sc. degrees in Chemical Engineering and Biochemistry, and a Doctorate in Medical Science from the University of Copenhagen.

Dr. Braestrup was previously President and Chief Executive Officer at H. Lundbeck A/S. He also formerly held the positions of Vice President of Pharmaceutical Research, President of the CNS Division, and President of the Diabetes Care Division at Novo Nordisk A/S, and Head of Preclinical Drug Research with Schering AG.

Erik Walldén, CEO at Gyros, commented: “We welcome Claus to the Board of Directors. His excellent scientific background and many years’ experience within the biotech and pharmaceutical industry will be a great asset to Gyros.”

Advertisement